Tenaya Therapeutics (TNYA) Current Assets (2020 - 2026)
Tenaya Therapeutics (TNYA) posted quarterly Current Assets of $96.6 million for Q1 2026, up 2.2% year-over-year from $94.5 million in Q1 2025, and down 8.55% quarter-over-quarter from $105.6 million in Q4 2025.
Tenaya Therapeutics (TNYA) Current Assets (2020 - 2026) Analysis & Trends
Tenaya Therapeutics' Current Assets history runs 7 years deep, the most recent figure standing at $96.6 million for Q1 2026.
- In Q1 2026, Current Assets rose 2.2% year-over-year to $96.6 million; the TTM figure through Mar 2026 stood at $96.6 million (up 2.2% YoY), while the FY2025 annual figure was $105.6 million, up 56.71% from the prior year.
- Current Assets for Q1 2026 stood at $96.6 million, down from $105.6 million in the prior quarter.
- The five-year high for Current Assets was $213.8 million in Q1 2022, with the low at $61.2 million in Q3 2025.
- The 5-year median for Current Assets is $111.6 million (2023), against an average of $123.7 million.
- Peak annual rise in Current Assets reached 64.01% in 2022, while the deepest fall reached 44.85% in 2022.
- Tenaya Therapeutics' Current Assets stood at $193.8 million in 2022, then sank by 42.41% to $111.6 million in 2023, then tumbled by 39.62% to $67.4 million in 2024, then soared by 56.71% to $105.6 million in 2025, then slipped by 8.55% to $96.6 million in 2026.
- Business Quant data shows TNYA's Current Assets at $96.6 million in Q1 2026, $105.6 million in Q4 2025, and $61.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.61 Bn | 131.75 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 86.70 Bn | 78.71 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 65.28 Bn | 60.09 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 59.14 Bn | 54.00 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 42.13 Bn | 37.03 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 31.83 Bn | 28.52 Bn | 992.69 Mn | 4.62 Bn |
| 7 | BioNTech SE | 28.07 Bn | 9.68 Bn | 668.28 Mn | 18.80 Bn |
| 8 | Insmed | 27.54 Bn | 26.38 Bn | 358.27 Mn | 1.63 Bn |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - | 1.76 Bn |
| 10 | Tenaya Therapeutics | 153.41 Mn | 153.41 Mn | - | 86.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 86.01 Mn |
| Mar 31, 2026 | 96.56 Mn |
| Dec 31, 2025 | 105.59 Mn |
| Sep 30, 2025 | 61.24 Mn |
| Jun 30, 2025 | 75.88 Mn |
| Mar 31, 2025 | 94.49 Mn |
| Dec 31, 2024 | 67.38 Mn |
| Sep 30, 2024 | 85.33 Mn |
| Jun 30, 2024 | 105.03 Mn |
| Mar 31, 2024 | 128.70 Mn |
| Dec 31, 2023 | 111.58 Mn |
| Sep 30, 2023 | 126.83 Mn |
| Jun 30, 2023 | 138.91 Mn |
| Mar 31, 2023 | 154.63 Mn |
| Dec 31, 2022 | 193.75 Mn |
| Sep 30, 2022 | 157.07 Mn |
| Jun 30, 2022 | 185.69 Mn |
| Mar 31, 2022 | 213.78 Mn |
| Dec 31, 2021 | 255.36 Mn |
| Sep 30, 2021 | 284.82 Mn |